3D Bioprinting Market is Expected to Grow with a CAGR of 13.6% from 2022 to 2028
3D Bioprinting is a process of printing structures in biomedical with the use of biological molecules, biomaterials, and viable cells. 3D Bioprinting is the impeachment of biological elements in a fashion which is layer-by-layer to create 3D structures such as organs and tissues. Bioprinting is treated as a piece of additive manufacturing which includes the formation of materials that are necessary for industrial end-users. 3D bioprinting starts with an appropriate microarchitecture and that is stabilized further by scaffolds of tissues and cells while seeing the reaction of manufacturing especially on cell viability.
The development of the market for 3D bioprinting is driven mainly by the technological advancements in 3D biomaterials and bioprinters, rising 3D bioprinting use in the cosmetology and pharmaceutical industries, and increasing private and public funding to support research activities in bioprinting. These determinants have prompted players to strengthen and improve their current distribution and manufacturing capabilities, particularly in developing markets, which are likely to see the highest growth.
Magnetic levitation is likely to expand at a significant rate over the coming years. The lucrative growth is owing to the cost-efficiency related to the technology. It is likely to solve above 80.0% errors with its advanced features, improved speed, and precision in 3D bioprinting. Bioprinters are also used for vascular muscle printing, toxicity screening, and human cell regeneration. BioAssay has developed a structure that is tissue-like, with the help of devices that are magnetic levitation-based. These devices are expected to witness dull growth in the coming years due to an increase in newer technologies usage.
The 3D Bioprinting Market globally is likely to witness substantial growth in the coming years owing to factors like advancements in technology for manufacturing customized items, a rise in the aged population, and an increase in focus on Research & Development investment. Additionally, the rise in 3D printing usage in cosmetic inventions and surgeries in 3D bioprinting is likely to supplement the market growth further in the coming years. Furthermore, the huge gap between the supply and demand of organ transplants signifies a high requirement amongst the doctors and the patients and the developing 3D bioprinting technologies which has the potential in filling this gap.
North America accounted for the largest share of the market for 3D Bioprinting. This can be driven by the rising research activities, increasing organ transplant demand, rising number of initiatives by key players for broadening their presence in the Asia Pacific, and adoption of stem cell research in various Asia Pacific nations. India and China are likely to offer substantial growth opportunities for market players operating in the market for 3D bioprinting, due to the rising government bodies support, rising demand for surgeries in cosmetics, and the existence of less-strict regulations and requirement of data in their healthcare systems respectively.
Some of the prominent players operating in the Global 3D Bioprinting Market are Envisiontec, Inc., Organovo Holdings, Inc., Inventia Life Science PTY LTD, Poietis, Vivax Bio, LLC, Allevi, Cyfuse Biomedical K.K., 3D Bioprinting Solutions, Cellink Global, Regemat 3D S.L..
Browse the full Report - 3d Bioprinting Market by Technology (Inkjet-based, Magnetic Levitation, Syringe-based, Laser-based), by Application (Medical, Dental, Biosensors, Consumer/Personal Product Testing), by Region (North America, Latin America, Europe, Asia Pacific) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)